131 related articles for article (PubMed ID: 31336176)
1. Subcutaneous vaccination using injectable biodegradable hydrogels for long-term immune response.
Lee ALZ; Yang C; Gao S; Hedrick JL; Yang YY
Nanomedicine; 2019 Oct; 21():102056. PubMed ID: 31336176
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable Strain-Promoted Click Hydrogels for Encapsulation of Drug-Loaded Nanoparticles and Sustained Release of Therapeutics.
Ono RJ; Lee ALZ; Voo ZX; Venkataraman S; Koh BW; Yang YY; Hedrick JL
Biomacromolecules; 2017 Aug; 18(8):2277-2285. PubMed ID: 28682629
[TBL] [Abstract][Full Text] [Related]
3. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable Cationic Polycarbonates as Vaccine Adjuvants.
Lee ALZ; Yang C; Gao S; Wang Y; Hedrick JL; Yang YY
ACS Appl Mater Interfaces; 2020 Nov; 12(47):52285-52297. PubMed ID: 33179910
[TBL] [Abstract][Full Text] [Related]
5. Injectable biodegradable hydrogels from vitamin D-functionalized polycarbonates for the delivery of avastin with enhanced therapeutic efficiency against metastatic colorectal cancer.
Lee AL; Ng VW; Gao S; Hedrick JL; Yang YY
Biomacromolecules; 2015 Feb; 16(2):465-75. PubMed ID: 25543531
[TBL] [Abstract][Full Text] [Related]
6. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
[TBL] [Abstract][Full Text] [Related]
7. H
Fan Y; Bai T; Tian Y; Zhou B; Wang Y; Yang L
Drug Des Devel Ther; 2021; 15():209-222. PubMed ID: 33488068
[TBL] [Abstract][Full Text] [Related]
8. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules.
Sexton A; Whitney PG; Chong SF; Zelikin AN; Johnston AP; De Rose R; Brooks AG; Caruso F; Kent SJ
ACS Nano; 2009 Nov; 3(11):3391-400. PubMed ID: 19824668
[TBL] [Abstract][Full Text] [Related]
9. The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.
Wafa EI; Geary SM; Goodman JT; Narasimhan B; Salem AK
Acta Biomater; 2017 Mar; 50():417-427. PubMed ID: 28063991
[TBL] [Abstract][Full Text] [Related]
10. In situ chemically crosslinked injectable hydrogels for the subcutaneous delivery of trastuzumab to treat breast cancer.
Lo YW; Sheu MT; Chiang WH; Chiu YL; Tu CM; Wang WY; Wu MH; Wang YC; Lu M; Ho HO
Acta Biomater; 2019 Mar; 86():280-290. PubMed ID: 30616077
[TBL] [Abstract][Full Text] [Related]
11. Hydrogels with prolonged release of therapeutic antibody: Block junction chemistry modification of 'ABA' copolymers provides superior anticancer efficacy.
Yang C; Lee A; Gao S; Liu S; Hedrick JL; Yang YY
J Control Release; 2019 Jan; 293():193-200. PubMed ID: 30521830
[TBL] [Abstract][Full Text] [Related]
12. Production of Adjuvant-Loaded Biodegradable Particles for Use in Cancer Vaccines.
de Barros CM; Wafa EI; Chitphet K; Ahmed K; Geary SM; Salem AK
Methods Mol Biol; 2017; 1494():201-213. PubMed ID: 27718195
[TBL] [Abstract][Full Text] [Related]
13. Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine.
Wafa EI; Geary SM; Ross KA; Goodman JT; Narasimhan B; Salem AK
Nanomedicine; 2019 Oct; 21():102055. PubMed ID: 31319179
[TBL] [Abstract][Full Text] [Related]
14. Injectable Coacervate Hydrogel for Delivery of Anticancer Drug-Loaded Nanoparticles in vivo.
Lee ALZ; Voo ZX; Chin W; Ono RJ; Yang C; Gao S; Hedrick JL; Yang YY
ACS Appl Mater Interfaces; 2018 Apr; 10(16):13274-13282. PubMed ID: 29595244
[TBL] [Abstract][Full Text] [Related]
15. Modulation of injectable hydrogel properties for slow co-delivery of influenza subunit vaccine components enhance the potency of humoral immunity.
Saouaf OM; Roth GA; Ou BS; Smith AAA; Yu AC; Gale EC; Grosskopf AK; Picece VCTM; Appel EA
J Biomed Mater Res A; 2021 Nov; 109(11):2173-2186. PubMed ID: 33955657
[TBL] [Abstract][Full Text] [Related]
16. Chitosan hydrogel vaccine generates protective CD8 T cell memory against mouse melanoma.
Highton AJ; Kojarunchitt T; Girardin A; Hook S; Kemp RA
Immunol Cell Biol; 2015 Aug; 93(7):634-40. PubMed ID: 25708538
[TBL] [Abstract][Full Text] [Related]
17. Degradable and Injectable Hydrogel for Drug Delivery in Soft Tissues.
Pertici V; Pin-Barre C; Rivera C; Pellegrino C; Laurin J; Gigmes D; Trimaille T
Biomacromolecules; 2019 Jan; 20(1):149-163. PubMed ID: 30376309
[TBL] [Abstract][Full Text] [Related]
18. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
[No Abstract] [Full Text] [Related]
19. A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations.
Jia Y; Akache B; Deschatelets L; Qian H; Dudani R; Harrison BA; Stark FC; Chandan V; Jamshidi MP; Krishnan L; McCluskie MJ
Int J Pharm; 2019 Apr; 561():187-196. PubMed ID: 30836154
[TBL] [Abstract][Full Text] [Related]
20. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization.
Wei J; Xue W; Yu X; Qiu X; Liu Z
J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
